RxSight, Inc. SEC filings RXST
RxSight, Inc. has 474 filings in SEC EDGAR's recent list, going back to Jul 30, 2002. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SC TO-I/A | Filing | Sep 8, 2026 | — |
| SC TO-I/A | Filing | Aug 25, 2026 | — |
| SC TO-I | Filing | Aug 10, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | May 29, 2026 | — |
| EFFECT | Filing | Feb 26, 2026 | — |
| POSASR | Filing | Feb 13, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | May 20, 2025 | — |
| ARS/A | Filing | Apr 21, 2025 | Dec 31, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 16, 2024 | — |
| EFFECT | Filing | Aug 12, 2022 | — |
| CORRESP | Letter to the SEC | Aug 10, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2022 | — |
| SEC STAFF LETTER | Filing | Jul 29, 2021 | — |
| EFFECT | Filing | Jul 29, 2021 | — |
| CERT | Filing | Jul 29, 2021 | — |
| 8-A12B | Filing | Jul 28, 2021 | — |
| CORRESP | Letter to the SEC | Jul 27, 2021 | — |
| CORRESP | Letter to the SEC | Jul 27, 2021 | — |
| CORRESP | Letter to the SEC | Jul 22, 2021 | — |
| SEC STAFF LETTER | Filing | Jul 9, 2021 | — |
| CORRESP | Letter to the SEC | Jul 9, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2021 | — |
| DRS/A | Filing | Jun 24, 2021 | — |
| DRSLTR | Filing | Jun 23, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2021 | — |
| DRS | Filing | May 17, 2021 | — |
| D/A | Filing | Apr 3, 2017 | — |
| D | Filing | Mar 8, 2017 | — |
| D/A | Filing | Mar 20, 2014 | — |
| D/A | Filing | Oct 8, 2013 | — |
| D/A | Filing | Jan 15, 2013 | — |
| D | Filing | Oct 18, 2012 | — |
| D | Filing | Oct 24, 2011 | — |
| D/A | Filing | Aug 27, 2010 | — |
| D | Filing | Sep 4, 2009 | — |
| REGDEX | Auto-generated paper document | May 21, 2007 | — |
| REGDEX | Auto-generated paper document | Apr 27, 2005 | — |
| REGDEX | Auto-generated paper document | May 14, 2003 | — |
| REGDEX | Auto-generated paper document | Jul 30, 2002 | — |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Ophthalmic Goods (SIC 3851)
- Listed as
- RXST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Aliso Viejo, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1111485
- Former names
- CALHOUN VISION INC (until Mar 20, 2014)
Other Ophthalmic Goods companies
- Alcon Inc ALC
- Cooper Companies, Inc. COO
- Bausch & Lomb Corp BLCO
- Warby Parker Inc. WRBY
- National Vision Holdings, Inc. EYE
- Staar Surgical Co STAA
- Innovative Eyewear Inc LUCY
Source: SEC EDGAR filings. This is company-reported data, not investment advice.